# GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery

> **NCT06324461** · PHASE4 · RECRUITING · sponsor: **The University of Hong Kong** · enrollment: 372 (estimated)

## Conditions studied

- Myocardial Injury

## Interventions

- **DRUG:** Dulaglutide 0.75mg subcutaneous injection

## Key facts

- **NCT ID:** NCT06324461
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-20
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 372 (ESTIMATED)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06324461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06324461, "GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06324461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*